|
Apr 16
|
The GLP-1 drug shortage is over. What’s next for the compounders?
|
|
Apr 16
|
Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?
|
|
Apr 15
|
Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts
|
|
Apr 15
|
Is Novo Nordisk A/S (NVO) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 15
|
Pfizer Halts Obesity Pill Development Amid Safety Concerns
|
|
Apr 15
|
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
|
|
Apr 15
|
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
|
|
Apr 14
|
Eli Lilly's Mounjaro launch in India ignites wave of weight-loss enquiries
|
|
Apr 14
|
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
|
|
Apr 14
|
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
|
|
Apr 14
|
Pfizer just had a big setback in its race for an Ozempic competitor
|
|
Apr 14
|
Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'
|
|
Apr 14
|
Pfizer discontinues GLP-1 pill trial, stock trades flat
|
|
Apr 11
|
Novo Remade Denmark. Then Came the Stock Selloff.
|
|
Apr 11
|
Here's Why Novo Nordisk (NVO) is a Strong Value Stock
|
|
Apr 11
|
Wall Street Pulls Back on the Weight-Loss Drug Hype
|
|
Apr 11
|
Pharma’s US manufacturing moment: Where companies are making the biggest moves
|
|
Apr 10
|
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
|
|
Apr 10
|
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs
|
|
Mar 17
|
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
|